World News
-
Diamyd Medical raises SEK 58.4 million through redemption of warrants
World | News | 0 Comment | 06 Dec, 2018
Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...Read more
-
Philips Recognized by Frost & Sullivan for Its PMAS system
World | News | 0 Comment | 06 Dec, 2018
Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Phi...Read more
-
Phagomed wins Austrian entrepreneurship award
World | News | 0 Comment | 05 Dec, 2018
Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phön...Read more
-
ResMed to acquire Propeller Health for $225M
World | News | 0 Comment | 05 Dec, 2018
Medical Devices company, ResMed has announced that it has entered a definitive agreement to acquire Propeller Health, a ...Read more
-
Domain Therapeutics collaborates with Boehringer Ingelheim
World | News | 0 Comment | 05 Dec, 2018
Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement wit...Read more
-
argenx collaborates with Cilag GmbH International
World | News | 0 Comment | 03 Dec, 2018
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...Read more
-
Editas Medicine announces pre-clinical data for treatment of Sickle Cell Diseases
World | News | 0 Comment | 03 Dec, 2018
Editas Medicine, a genome editing company has announced results from experiments to demonstrate expanded CRISPR genome e...Read more
-
Auris Health announces $220 M growth financing
World | News | 0 Comment | 03 Dec, 2018
Auris Health, Inc. has announced the close of a $220 million equity financing led by Partner Fund Management. New invest...Read more
-
Biocartis, AstraZeneca aim faster lung cancer biomarker results
World | News | 0 Comment | 03 Dec, 2018
Biocartis Group NV, an innovative molecular diagnostics company, has entered into an agreement with AstraZeneca, a globa...Read more
-
FDA approves first treatment developed by Catalyst Pharma for LEMS
World | News | 0 Comment | 01 Dec, 2018
The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton m...Read more
-
Roche buys Jecure Therapeutics
World | News | 0 Comment | 29 Nov, 2018
Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory dise...Read more
-
GE Healthcare to open biotech manufacturing centre in UK
World | News | 0 Comment | 28 Nov, 2018
GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SB...Read more
-
World | News | 0 Comment | 28 Nov, 2018
Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific...Read more
-
Roivant launches Aruvant Sciences
World | News | 0 Comment | 28 Nov, 2018
US based pharma company Roivant Sciences and Cincinnati Children’s Hospital Medical centre has announced...Read more
-
Frazier Healthcare Partners adds experienced executive search professional to Life Sciences team
World | News | 0 Comment | 28 Nov, 2018
Frazier Healthcare Partners has announced Mimi Hancock, Ph.D. has joined its Life Sciences team as a Senior Advisor to a...Read more
-
Receptor Life Sciences announces senior leadership
World | News | 0 Comment | 28 Nov, 2018
Receptor Life Sciences has announced the appointment of Orrin Devinsky, M.D., as the company’s Chief Medical Offic...Read more
-
WHO introduces new digital platform addressing NCDs
World | News | 0 Comment | 28 Nov, 2018
The World Health Organization (WHO) has launched a new community-driven platform - the Knowledge Action Portal (KAP) - f...Read more
-
CURE Pharma gets USDEA nod to develop cannabinoid-based products
World | News | 0 Comment | 28 Nov, 2018
CURE Pharmaceutical, an innovative drug delivery and development company, has secured a new registration with the Drug E...Read more
